Quoin Pharmaceuticals Ltd - ADR

NASDAQ:QNRX   10:37:55 AM EDT
4.97
+0.06 (+1.22%)
Products

Quoin Pharmaceuticals Announces Receipt Of Constructive Scientific Advice From EMA For QRX003 Development In Europe

Published: 07/28/2022 12:48 GMT
Quoin Pharmaceuticals Ltd - ADR (QNRX) - Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice From Ema for Qrx003 Development in Europe.
Quoin Pharmaceuticals Ltd - Scientific Advice Was Received in Response to a Briefing Submission Document Filed by Quoin to Ema on May 26, 2022.
Quoin Pharmaceuticals Ltd - Continue to Expand Our Network of Supply and Distribution Agreements for Qrx003.